An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
- Sprache
-
Englisch
- Identifier
-
1285394704
Beteiligte Personen und Organisationen
Suwelack, Barbara
Dragun, Duska
Schenker, Peter
Hauser, Ingeborg A.
Witzke, Oliver
Hugo, Christian
Kamar, Nassim
Merville, Pierre
Junge, Martina
Thaiss, Friedrich
Nashan, Björn
Almartine, Eric
Dantal, Jacques
Dragun, Duska
Feldkamp, Thorsten
Hauser, Ingeborg A.
Hazzan, Marc
Heyne, Nils
Hugo, Christian
Kamar, Nassim
Lang, Philippe
Lehner, Frank
Le Meur, Yannick
Lutz, Jens
Merville, Pierre
Morelon, Emmanuel
Moulin, Bruno
Mousson, Christiane
Muehlfeld, Anja
Nashan, Björn
Pisarski, Przemyslaw
Rondeau, Eric
Schenker, Peter
Sommerer, Claudia
Suwelack, Barbara
Thaiss, Friedrich
Thierry, Antoine
Wiesener, Michael
Witzke, Oliver
Athena Study Group
Dragun, Duska
Schenker, Peter
Hauser, Ingeborg A.
Witzke, Oliver
Hugo, Christian
Kamar, Nassim
Merville, Pierre
Junge, Martina
Thaiss, Friedrich
Nashan, Björn
Almartine, Eric
Dantal, Jacques
Dragun, Duska
Feldkamp, Thorsten
Hauser, Ingeborg A.
Hazzan, Marc
Heyne, Nils
Hugo, Christian
Kamar, Nassim
Lang, Philippe
Lehner, Frank
Le Meur, Yannick
Lutz, Jens
Merville, Pierre
Morelon, Emmanuel
Moulin, Bruno
Mousson, Christiane
Muehlfeld, Anja
Nashan, Björn
Pisarski, Przemyslaw
Rondeau, Eric
Schenker, Peter
Sommerer, Claudia
Suwelack, Barbara
Thaiss, Friedrich
Thierry, Antoine
Wiesener, Michael
Witzke, Oliver
Athena Study Group
- DOI
-
10.18154/RWTH-CONV-241505
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
10.05.2023, 10:54 MESZ
Beteiligte
- Suwelack, Barbara
- Dragun, Duska
- Schenker, Peter
- Hauser, Ingeborg A.
- Witzke, Oliver
- Hugo, Christian
- Kamar, Nassim
- Merville, Pierre
- Junge, Martina
- Thaiss, Friedrich
- Nashan, Björn
- Almartine, Eric
- Dantal, Jacques
- Dragun, Duska
- Feldkamp, Thorsten
- Hauser, Ingeborg A.
- Hazzan, Marc
- Heyne, Nils
- Hugo, Christian
- Kamar, Nassim
- Lang, Philippe
- Lehner, Frank
- Le Meur, Yannick
- Lutz, Jens
- Merville, Pierre
- Morelon, Emmanuel
- Moulin, Bruno
- Mousson, Christiane
- Muehlfeld, Anja
- Nashan, Björn
- Pisarski, Przemyslaw
- Rondeau, Eric
- Schenker, Peter
- Sommerer, Claudia
- Suwelack, Barbara
- Thaiss, Friedrich
- Thierry, Antoine
- Wiesener, Michael
- Witzke, Oliver
- Athena Study Group
Ähnliche Objekte (12)
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus : an analysis from the randomized ZEUS study
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy : an analysis of two randomized, multicenter trials
Clinical validation of a novel enzyme-linked immunosorbent spot assay-based in vitro diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study
Early Everolimus-Facilitated Reduced Tacrolimus in Liver Transplantation : Results From the Randomized HEPHAISTOS Trial
Noninvasive Diagnosis of Acute Rejection in Renal Transplant Patients Using Mass Spectrometric Analysis of Urine Samples : A Multicenter Diagnostic Phase III Trial
Time on previous renal replacement therapy is associated with worse outcomes of COVID-19 in a regional cohort of kidney transplant and dialysis patients
Renal function and patient-reported outcomes in stable kidney transplant patients following conversion from twice-daily immediate-release tacrolimus to once-daily prolonged-release tacrolimus: a 12-month observational study in routine clinical practice in Germany (ADAGIO)
Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study
Correction: Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus : an analysis from the randomized ZEUS study
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy : an analysis of two randomized, multicenter trials
Clinical validation of a novel enzyme-linked immunosorbent spot assay-based in vitro diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study
Early Everolimus-Facilitated Reduced Tacrolimus in Liver Transplantation : Results From the Randomized HEPHAISTOS Trial
Noninvasive Diagnosis of Acute Rejection in Renal Transplant Patients Using Mass Spectrometric Analysis of Urine Samples : A Multicenter Diagnostic Phase III Trial
Time on previous renal replacement therapy is associated with worse outcomes of COVID-19 in a regional cohort of kidney transplant and dialysis patients
Renal function and patient-reported outcomes in stable kidney transplant patients following conversion from twice-daily immediate-release tacrolimus to once-daily prolonged-release tacrolimus: a 12-month observational study in routine clinical practice in Germany (ADAGIO)
Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study
Correction: Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus : an analysis from the randomized ZEUS study
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy : an analysis of two randomized, multicenter trials
Clinical validation of a novel enzyme-linked immunosorbent spot assay-based in vitro diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study
Early Everolimus-Facilitated Reduced Tacrolimus in Liver Transplantation : Results From the Randomized HEPHAISTOS Trial
Noninvasive Diagnosis of Acute Rejection in Renal Transplant Patients Using Mass Spectrometric Analysis of Urine Samples : A Multicenter Diagnostic Phase III Trial
Time on previous renal replacement therapy is associated with worse outcomes of COVID-19 in a regional cohort of kidney transplant and dialysis patients
Renal function and patient-reported outcomes in stable kidney transplant patients following conversion from twice-daily immediate-release tacrolimus to once-daily prolonged-release tacrolimus: a 12-month observational study in routine clinical practice in Germany (ADAGIO)
Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study